News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Odyssey Therapeutics Announces Partnership to Drive AI-Powered Small Molecule Drug Discovery
Friday, April 05, 2024Odyssey Therapeutics Inc a pioneering biotechnology company specializing in nextgeneration precision medicines announced a significant research collaboration with Janssen Pharmaceutica
MiNA Therapeutics and Nippon Shinyaku Team Up to Develop RNAa Therapeutics for Rare Neurodegenerative Diseases
Friday, April 05, 2024MiNA Therapeutics a leader in small activating RNA therapeutics has announced a collaborative research and licensing agreement option with Nippon Shinyaku Co Ltd
SimBioSys and General Inception Form Strategic Partnership to Speed Up Cancer Drug Development
Thursday, April 04, 2024SimBioSys a leader in precision oncology and General Inception a global company Igniter have announced a strategic partnership aimed at transforming oncology drug development
Merz Announces Asset Acquisition Agreement with a US Biotechnology Company
Wednesday, April 03, 2024Merz Therapeutics a division of the Frankfurtbased Merz Group has initiated a deal to acquire two established medications from Acorda Therapeutics a Nasdaqlisted company
Mosaic Biosciences Strengthens Its Position in Drug Discovery and Development
Wednesday, April 03, 2024Mosaic Biosciences a prominent player in the field of drug discovery has announced the appointment of two distinguished leaders to its team Dr Malavi Madireddi as Senior Vice President of Drug Discovery
BioInvent Enters Clinical Trial Collaboration and Supply Agreement with MSD to Assess BI-1910 Combined with KEYTRUDA®
Tuesday, April 02, 2024BioInvent International AB a biotechnology company specializing in the development of innovative immunemodulatory antibodies for cancer immunotherapy has announced a collaboration and supply
Utilizing Turbine and Harmonic Discovery Pair Simulation Alongside Expertise in Multi-Target Kinase Inhibition Chemistry for the Development of a Novel Cancer Therapy
Monday, April 01, 2024Turbine a company pioneering the development of the worlds first predictive simulation of patient biology
Gilead and Xilio Enter Exclusive License Agreement for Tumor-Activated IL-12 Program
Saturday, March 30, 2024Gilead Sciences Inc and Xilio Therapeutics Inc have recently announced an exclusive agreement to collaborate on the development and commercialization of Xilios Phase tumoractivated IL program
Confo Therapeutics Secures VLAIO Grant for Advancing Drug Discovery and Development in Endocrine and Metabolic Diseases
Friday, March 29, 2024Confo Therapeutics a pioneer in the field of developing innovative medicines targeting Gprotein coupled receptors has announced today that it has received a substantial EUR million grant from Flanders
Intravacc and Primrose Bio Collaborate to Enhance Conjugate Vaccine Development
Thursday, March 28, 2024Intravacc a globally recognized contract development and manufacturing organization specializing in infectious disease and therapeutic vaccines has announced a strategic partnership with Primrose Bio
